lifestyle.cfxmagazine.com

Author: NetraMark Holdings Inc.

NetraMark Appoints Dr. Panteli Theocharous As Fractional Chief Medical Officer, Strengthening Clinical Leadership To Accelerate Global Adoption of NetraAI

May 4, 2026
NetraMark To Open The Market At The Toronto Stock Exchange On May 5, 2026

April 30, 2026
NetraMark Announces Strategic Oncology Research Collaboration with Fondazione per la Medicina Personalizzata to Analyze Landmark ROME Trial Dataset

March 25, 2026
NetraMark Unveils AI-Discovered Treatment-Responsive Subgroups in A4 Alzheimer’s Trial at AD/PD Conference

March 19, 2026
NetraMark Signs Contract With Global Biopharmaceutical Company to Analyze Phase 2 Depression Trial Data

March 11, 2026
NetraMark Closes Final Tranche of $3.5 Million Private Placement

February 19, 2026
Netramark Announces Uplisting to Toronto Stock Exchange

February 13, 2026
NetraMark Strengthens Board Of Directors

January 29, 2026
NetraMark Engages LodeRock Advisors for Strategic Investor Relations and Capital Markets Communications Services

January 22, 2026